Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Draghi Has Ruined Europe
Well, the central bankers are really beginning to fail in a very public way. Kuroda has obviously made a complete shitshow out of the senior citizens colony known as Japan. Yellen has, so far, been given a free pass by the blinkered, pig-ignorant American public, who are too busy watching the Kardashians, but trust Tim on this, she will have her comeuppance. […]
Zynga Inc. Stock Offers An Opportunity To Value Investors?
With its IPO priced at $10 per share back in December of 2011, Zynga (NASDAQ:ZNGA) has fallen more than 75% since. Inconsistent revenues, negative margins, and a declining user base have dragged the company down to alarming lows. However, Zynga still carries a very strong balance sheet and is trading only slightly above its book value, which […]
Amazon Will Climb Throughout 2016
Considering the amazing size of Amazon (AMZN) already, it’s hard to imagine that the company will be able to climb much higher, that is, until you take a look at what the company has in the works. You see, Amazon has three big things in the works right now that will likely send the stock […]
Buy With Confidence: The Nasdaq Biotechnology ETF Finally Breaks Out
In January of this year, I finally gave up on the near-term prospects of the iShares Nasdaq Biotechnology ETF (IBB) reversing what I called “The Clinton Bash.” After a rapid cascade downward from The Clinton Bash, IBB made three attempts from November to December, 2015 to reverse those losses. Those attempts came to a crashing […]
Nearly A Trillion In Short Interest Despite ‘Rally’
If there’s a trillion bucks AGAINST the rally, then imagine how much money is PUSHING the rally for it to continue. Now, where would this kind of money come from? It ain’t you and I, that’s for sure – pardon the very bad grammar! It is becoming pretty obvious that the big money wants to […]
EC HH Manufacturing In America: Are American Jobs Worth $30 Socks?
My younger daughter doesn’t conform to, well, much of anything. As a very young girl, she insisted on doing her own hair. She liked pony tails – lots of them – but as a four or five-year-old, she didn’t have much skill at getting them right. This meant that she often had 11 or 12 […]
Great Graphic: WSJ Survey Of Fed Expectations
This Great Graphic shows the results of the last three Wall Street Journal survey of business and academic economists on the outlook for Fed policy. The key take away is that despite all the talk and ink spilled on the shifting Fed stance and the split within the FOMC, economists views did not change much […]
The Red Dragon Roars While The Fed Waits
It’s as though I know what I’m talking about… Several months ago when I was speaking at our Total Wealth Symposium in The Bahamas, I laid out a simple, straightforward path that would see China devalue its currency which would, in turn, lead to the Federal Reserve finally finding the cover it needs to raise interest rates […]
Deutsche Bank Is Crashing Again As European Banks Slide To Crisis Lows
As of this moment, various European banks but most prominently Deutsche Bank… … as well as Credit Suisse and RBS, have been crashing back to lows hit in early February and then all the way back to the March 2009 “the world is ending” lows.We commented on this yesterday using, ironically enough, a note by […]
Valeant Pharmaceuticals Intl Inc. Soars As Debt Deal Reached
Valeant Pharmaceuticals Intl Inc. (VRX) obtained consent from over half of loan holders to push back regulatory filing deadlines and loosen financial conditions on the loans. The week marks a series of positive developments for the struggling drug maker and, mirroring the positive developments, Valeant shares surged $5.44, or 19% Wednesday to close at $34.17, making the latest increase […]
